Provided herein are novel piperazine compounds and pharmaceutical compositions thereof comprising the piperazine compounds for inhibiting serotonin reuptake and/or acting as 5-HT1A receptor agonists. Also provided herein are methods for preparing the novel piperazine compounds and pharmaceutical compositions thereof, and uses of them in treating central nervous system (CNS) dysfunction.
本文提供了新颖的
哌嗪化合物及其制药组合物,包括用于抑制
血清素再摄取和/或作为5-HT1A受体激动剂的
哌嗪化合物。本文还提供了制备新颖的
哌嗪化合物和制药组合物的方法,以及它们在治疗中枢神经系统(CNS)功能障碍中的用途。